GLI1 expression is an important prognostic factor that contributes to the poor prognosis of rhabdomyosarcoma.

GLI1 expression is an important prognostic factor that contributes to the poor prognosis of rhabdomyosarcoma.
复制标题

GLI1表达是导致横纹肌肉瘤预后不良的重要预后因素。

DOI:
10.14670/hh-11-682
复制
发表时间:
2016-03
期刊:
Histol Histopathol
影响因子:
--
通讯作者:
Feng Li
Feng Li
中科院分区:
其他
文献类型:
--
作者:
Yuanyuan Wang;Chao Sun;Jinfang Jiang;Yuwen Xie;Bingcheng Li;Xiaobin Cui;Yunzhao Chen;Chunxia Liu;Feng Li

文献摘要

参考文献

相似文献

横纹肌肉瘤(RMS)中GLI 1和MDM 2基因扩增或表现出拷贝数增加。在这里,我们使用免疫组化来确定GLI 1和MDM 2蛋白表达与RMS的几个临床病理变量之间的关系。GLI 1和MDM 2的阳性率分别为61.36%和13.64%。GLI 1表达与PAX 3-FOXO 1融合基因的存在(P=0.040)和淋巴结转移(P=0.034)相关,并且发现GLI 1表达与总生存期(OS)之间存在显著相关性(P=0.008)。然而,MDM 2的表达与任何临床病理参数或OS之间没有关联。因此,GLI 1可能是RMS患者预后不良的生物标志物,并且其本身可能是治疗靶点。这与MDM 2在RMS病理学中明显缺乏临床重要性形成对比,至少在我们检查的队列中是如此。
The GLI1 and MDM2 genes are amplified or exhibit copy number gains in rhabdomyosarcoma (RMS). Here, we used immunohistochemistry to determine the relationships between GLI1 and MDM2 protein expression and several clinicopathological variables of RMS. GLI1 and MDM2-positivity rates were 61.36% and 13.64%, respectively. GLI1 expression correlated with presence of the PAX3-FOXO1 fusion gene (P=0.040) and lymph node metastasis (P=0.034), and a significant association was found between GLI1 expression and overall survival (OS) (P=0.008). However, there was no association between MDM2 expression and any of the clinicopathological parameters or OS. Thus, GLI1 may be a biomarker of poor prognosis in RMS patients, and could itself be a therapeutic target. This contrasts with the apparent lack of clinical importance of MDM2 in RMS pathology, at least in the cohorts we examined.
DOI: 10.1136/bmjopen-2014-006030
发表时间: 2015-01-08
期刊: BMJ open
影响因子: 2.9
作者:
Norman G;Fayter D;Lewis-Light K;Chisholm J;McHugh K;Levine D;Jenney M;Mandeville H;Gatz S;Phillips B
通讯作者: Phillips B
人胰腺癌中 DNMT1 和 DNMT3a 的表达受 GLI1 调节。
DOI: 10.1371/journal.pone.0027684
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者:
He S;Wang F;Yang L;Guo C;Wan R;Ke A;Xu L;Hu G;Xu X;Shen J;Wang X
通讯作者: Wang X
DOI: 10.1007/bf01535205
发表时间: 1987-05-01
期刊: SOMATIC CELL AND MOLECULAR GENETICS
影响因子: --
作者:
CAHILLYSNYDER, L;YANGFENG, T;GEORGE, DL
通讯作者: GEORGE, DL
DOI: --
发表时间: 1996-11
期刊: Cancer research
影响因子: 11.2
作者:
G. Reifenberger;Koichi Ichimura;J. Reifenberger;Elkahloun Ag;Meltzer Ps;V. Collins
通讯作者: G. Reifenberger;Koichi Ichimura;J. Reifenberger;Elkahloun Ag;Meltzer Ps;V. Collins
DOI: 10.1136/jclinpath-2014-202434
发表时间: 2014-10
影响因子: 3.4
作者:
J. Choe;J. Yun;Y. Jeon;S. H. Kim;H. Choung;Sohee Oh;Mira Park;J. Kim
通讯作者: J. Choe;J. Yun;Y. Jeon;S. H. Kim;H. Choung;Sohee Oh;Mira Park;J. Kim